ロード中...
Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors
RRx-001 is an anticancer agent that subjects cancer cells to reactive oxygen/nitrogen species (ROS/RNS) and acts as an epigenetic modifier. We have used a thiol-bearing MRI contrast agent, Gd-LC7-SH, to investigate the pharmacodynamics of RRx-001 in CHP-100 Ewing's Sarcoma, HT-29 colorectal car...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731976/ https://ncbi.nlm.nih.gov/pubmed/29254266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18455 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|